A detailed history of Covestor LTD transactions in Geron Corp stock. As of the latest transaction made, Covestor LTD holds 34 shares of GERN stock, worth $138. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34
Previous 49 30.61%
Holding current value
$138
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$4.17 - $4.99 $62 - $74
-15 Reduced 30.61%
34 $0
Q1 2024

May 10, 2024

SELL
$1.75 - $3.44 $5 - $10
-3 Reduced 5.77%
49 $0
Q4 2023

Feb 09, 2024

SELL
$1.74 - $2.31 $8 - $11
-5 Reduced 8.77%
52 $0
Q3 2023

Nov 13, 2023

SELL
$2.11 - $3.28 $16 - $26
-8 Reduced 12.31%
57 $0
Q2 2023

Aug 11, 2023

BUY
$1.97 - $3.69 $128 - $239
65 New
65 $0

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.53B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.